Enter Your Practice Information





Yes No

Yes No


X
x

Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
    Proceedings
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  Sign up now for:
Become a Member

Journal May 2012 (Vol 34, No 5)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Hypercoagulability in Dogs: Treatment by Dianne Kittrell , DVM, DACVIM, Larry Berkwitt , DVM, DACVIM

1. Which statement regarding venous thrombi is false?
2. Which statement regarding arterial thrombi is true?
3. Which of the following statements regarding antiplatelet drugs is true?
4. Heparin enhances the activity of which anticoagulant?
5. Which statement regarding unfractionated heparin or LMWH is true?
6. Which of the following is a recognized limitation of unfractionated heparin use?
7. Which is not a characteristic of LMWH?
8. Which statement regarding warfarin therapy is false?
9. _______ requires close monitoring to prevent hemorrhagic complications associated with its use.
10. Which statement regarding fibrinolytic therapy is false?
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More
Subscribe